Variant report
Variant | esv10989 |
---|---|
Chromosome Location | chr14:105368860-105374042 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:31)
- CpG islands (count:367)
- Chromatin interactive region (count:2)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:31 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CBX3 | chr14:105369835-105370253 | K562 | blood: | n/a | n/a |
2 | CTCF | chr14:105369860-105370010 | WI-38 | lung: | n/a | n/a |
3 | EP300 | chr14:105371734-105372019 | GM12878 | blood: | n/a | n/a |
4 | EP300 | chr14:105372130-105372777 | GM12878 | blood: | n/a | n/a |
5 | FAM48A | chr14:105370679-105370852 | GM12878 | blood: | n/a | n/a |
6 | GABPA | chr14:105371543-105371746 | Hela-S3 | cervix: | n/a | n/a |
7 | GABPA | chr14:105371814-105372098 | Hela-S3 | cervix: | n/a | n/a |
8 | GABPA | chr14:105371809-105373361 | HepG2 | liver: | n/a | n/a |
9 | KAP1 | chr14:105373638-105374358 | HEK293 | kidney: | n/a | n/a |
10 | KAP1 | chr14:105369649-105370177 | K562 | blood: | n/a | n/a |
11 | KAP1 | chr14:105373453-105374272 | K562 | blood: | n/a | n/a |
12 | MAFK | chr14:105373360-105373399 | HepG2 | liver: | n/a | n/a |
13 | NFIC | chr14:105371264-105371628 | ECC-1 | luminal epithelium: | n/a | n/a |
14 | PAX5 | chr14:105372391-105372604 | GM12878 | blood: | n/a | n/a |
15 | PAX5 | chr14:105371487-105371692 | GM12878 | blood: | n/a | n/a |
16 | POLR2A | chr14:105372898-105373159 | H1-hESC | embryonic stem cell: | n/a | n/a |
17 | POU2F2 | chr14:105371500-105372774 | GM12878 | blood: | n/a | n/a |
18 | REST | chr14:105371505-105373047 | HepG2 | liver: | n/a | n/a |
19 | REST | chr14:105371472-105373380 | PANC-1 | pancreas: | n/a | n/a |
20 | REST | chr14:105371445-105373369 | U87 | brain: | n/a | n/a |
21 | SETDB1 | chr14:105369833-105370394 | U2OS | brain: | n/a | n/a |
22 | SETDB1 | chr14:105373608-105374217 | U2OS | brain: | n/a | n/a |
23 | SPI1 | chr14:105371068-105371333 | GM12891 | blood: | n/a | n/a |
24 | SRF | chr14:105371492-105372860 | GM12878 | blood: | n/a | n/a |
25 | STAT3 | chr14:105369951-105370137 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | TAL1 | chr14:105369602-105369880 | K562 | blood: | n/a | n/a |
27 | TCF12 | chr14:105371182-105371665 | ECC-1 | luminal epithelium: | n/a | n/a |
28 | TCF12 | chr14:105371166-105371643 | ECC-1 | luminal epithelium: | n/a | n/a |
29 | TCF3 | chr14:105371367-105373381 | GM12878 | blood: | n/a | n/a |
30 | ZNF143 | chr14:105369913-105370201 | K562 | blood: | n/a | n/a |
31 | ZNF143 | chr14:105373743-105373752 | H1-hESC | embryonic stem cell: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:105372186-105372236 | NHBE | bronchial: | n/a |
2 | chr14:105372186-105372236 | NHBE | bronchial: | n/a |
3 | chr14:105373082-105373132 | SKMC | muscle: | n/a |
4 | chr14:105372186-105372236 | PFSK-1 | brain: | n/a |
5 | chr14:105373391-105373441 | SK-N-MC | brain: | n/a |
6 | chr14:105373391-105373441 | LNCaP | prostate: | n/a |
7 | chr14:105372186-105372236 | SK-N-MC | brain: | n/a |
8 | chr14:105370983-105371033 | ovcar-3 | ovarian: | n/a |
9 | chr14:105372846-105372896 | HCF | heart: | n/a |
10 | chr14:105372186-105372236 | AG04449 | skin: | fetal |
11 | chr14:105371541-105371591 | NHBE | bronchial: | n/a |
12 | chr14:105373391-105373441 | SKMC | muscle: | n/a |
13 | chr14:105371541-105371591 | GM12891 | blood: | n/a |
14 | chr14:105372186-105372236 | HEK293 | kidney: | embryo |
15 | chr14:105371541-105371591 | HRPEpiC | eye: | n/a |
16 | chr14:105373082-105373132 | AG09309 | skin: | n/a |
17 | chr14:105372846-105372896 | BE2_C | brain: | n/a |
18 | chr14:105373082-105373132 | SK-N-SH_RA | brain: | n/a |
19 | chr14:105372186-105372236 | HRPEpiC | eye: | n/a |
20 | chr14:105373082-105373132 | SK-N-SH | brain: | n/a |
21 | chr14:105370983-105371033 | NT2-D1 | testis: | n/a |
22 | chr14:105373391-105373441 | NT2-D1 | testis: | n/a |
23 | chr14:105372186-105372236 | HCT-116 | colon: | n/a |
24 | chr14:105372186-105372236 | MCF-7 | breast: | n/a |
25 | chr14:105373391-105373441 | HEEpiC | esophagus: | n/a |
26 | chr14:105373391-105373441 | A549 | lung: | n/a |
27 | chr14:105371541-105371591 | Caco-2 | colon: | n/a |
28 | chr14:105373391-105373441 | HL-60 | blood: | n/a |
29 | chr14:105372846-105372896 | GM12892 | blood: | n/a |
30 | chr14:105370983-105371033 | BJ | skin: | n/a |
31 | chr14:105370983-105371033 | K562 | blood: | n/a |
32 | chr14:105373082-105373132 | HCM | heart: | n/a |
33 | chr14:105371541-105371591 | SK-N-SH_RA | brain: | n/a |
34 | chr14:105373082-105373132 | K562 | blood: | n/a |
35 | chr14:105373391-105373441 | BE2_C | brain: | n/a |
36 | chr14:105373391-105373441 | BJ | skin: | n/a |
37 | chr14:105371541-105371591 | AG09309 | skin: | n/a |
38 | chr14:105372186-105372236 | BE2_C | brain: | n/a |
39 | chr14:105372846-105372896 | CMK | blood: | n/a |
40 | chr14:105372186-105372236 | GM19239 | blood: | n/a |
41 | chr14:105373082-105373132 | GM12878 | blood: | n/a |
42 | chr14:105370983-105371033 | H1-hESC | embryonic stem cell: | embryo |
43 | chr14:105373082-105373132 | HL-60 | blood: | n/a |
44 | chr14:105372846-105372896 | LNCaP | prostate: | n/a |
45 | chr14:105371541-105371591 | LNCaP | prostate: | n/a |
46 | chr14:105373082-105373132 | NHBE | bronchial: | n/a |
47 | chr14:105370983-105371033 | GM12891 | blood: | n/a |
48 | chr14:105371541-105371591 | NHDF-neo | bronchial: | n/a |
49 | chr14:105371541-105371591 | H1-hESC | embryonic stem cell: | embryo |
50 | chr14:105371541-105371591 | AG04449 | skin: | fetal |
(count:2 , 50 per page) page:
1
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-KIAA0284-1 | chr14:105371069-105371327 | ENSG00000259067 |
2 | lnc-KIAA0284-1 | chr14:105370679-105370935 | ENSG00000259067 |
3 | lnc-KIAA0284-1 | chr14:105371474-105371541 | ENSG00000259067 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000259067 | TF binding region |
ENSG00000259067 | CpG island |
ENSG00000099814 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2841250 | chr14:105368868-105368869 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs2582540 | chr14:105368881-105368882 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs112175036 | chr14:105368976-105368977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs540591836 | chr14:105368999-105369000 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs560804057 | chr14:105369000-105369001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs143490858 | chr14:105369002-105369003 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs201101463 | chr14:105369022-105369023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs145638117 | chr14:105369026-105369027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs201960908 | chr14:105369035-105369036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs2841251 | chr14:105369056-105369057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs546372613 | chr14:105369074-105369075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs563071625 | chr14:105369078-105369079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs531883921 | chr14:105369084-105369085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs187287689 | chr14:105369092-105369093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs190977591 | chr14:105369127-105369128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs527661378 | chr14:105369190-105369191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs12894037 | chr14:105369235-105369236 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs570675737 | chr14:105369249-105369250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs147140286 | chr14:105369265-105369266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs369991362 | chr14:105369281-105369282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs72702010 | chr14:105369308-105369309 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs182274594 | chr14:105369314-105369315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs186597856 | chr14:105369324-105369325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs143345979 | chr14:105369326-105369327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs367986759 | chr14:105369327-105369328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs3055734 | chr14:105369345-105369346 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs370230534 | chr14:105369346-105369347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs191844807 | chr14:105369370-105369371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs535200076 | chr14:105369402-105369403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs375506112 | chr14:105369455-105369456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561405480 | chr14:105369492-105369493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs57482877 | chr14:105369517-105369518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs2841252 | chr14:105369601-105369602 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
34 | rs530441118 | chr14:105369606-105369607 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs540982125 | chr14:105369627-105369628 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs73355749 | chr14:105369645-105369646 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs182542124 | chr14:105369660-105369661 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs2582541 | chr14:105369671-105369672 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs563111245 | chr14:105369701-105369702 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs531921407 | chr14:105369728-105369729 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs188507891 | chr14:105369755-105369756 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs562180274 | chr14:105369775-105369776 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs2841253 | chr14:105369905-105369906 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs139459649 | chr14:105369988-105369989 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs150074525 | chr14:105370018-105370019 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs76000816 | chr14:105370033-105370034 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs533089567 | chr14:105370048-105370049 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs549640967 | chr14:105370086-105370087 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs374210954 | chr14:105370122-105370123 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs569535234 | chr14:105370133-105370134 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
cataract | 16735990 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Developmental delay | 21147756 | CNVD |
Cancer | 20164920 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 19435499 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Acute lymphoblastic leukemia | 20139093 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Non-small cell lung cancer | 18320023 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Congenital heart defect | 22367666 | CNVD |
Developmental delay | 22367666 | CNVD |
Genitourinary abnormalities | 22367666 | CNVD |
Intellectual disability | 22367666 | CNVD |
Microcephaly | 22367666 | CNVD |
Muscularhypotonia | 22367666 | CNVD |
Ocular coloboma | 22367666 | CNVD |
Teratozoospermia | 22367666 | CNVD |
Cervical cancer | 21062161 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 21990379 | CNVD |
Breast cancer | 16417655 | CNVD |
22q11 deletion syndrome | 22511897 | CNVD |
Cancer | 21129771 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Schizophrenia | 21399695 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
14q deletion syndrome | 22511897 | CNVD |
Epilepsy | 22083797 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 17440070 | CNVD |
Neurocytoma | 17123091 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Acute lymphoblastic leukemia | 17315016 | CNVD |
Lung cancer | 17086460 | CNVD |
Mortal | 21835882 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 17426248 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Schizophrenia | 20967226 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Schizophrenia | 23813976 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164919 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:105354000-105369800 | Weak transcription | HSMMtube | muscle |
2 | chr14:105365800-105370800 | Weak transcription | Fetal Lung | lung |
3 | chr14:105368000-105369600 | Weak transcription | GM12878-XiMat | blood |
4 | chr14:105369600-105371400 | ZNF genes & repeats | GM12878-XiMat | blood |
5 | chr14:105369800-105371000 | ZNF genes & repeats | HSMMtube | muscle |
6 | chr14:105370800-105371000 | Bivalent Enhancer | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr14:105370800-105371000 | Bivalent Enhancer | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr14:105370800-105371000 | Bivalent Enhancer | Primary B cells from peripheral blood | blood |
9 | chr14:105370800-105371000 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
10 | chr14:105370800-105371400 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
11 | chr14:105370800-105371400 | Enhancers | Fetal Lung | lung |
12 | chr14:105371000-105371200 | Bivalent/Poised TSS | Small Intestine | intestine |
13 | chr14:105371000-105371400 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
14 | chr14:105371000-105371400 | Flanking Active TSS | Ganglion Eminence derived primary cultured neurospheres | brain |
15 | chr14:105371000-105371600 | Bivalent Enhancer | Cortex derived primary cultured neurospheres | brain |
16 | chr14:105371200-105371400 | Bivalent Enhancer | Rectal Mucosa Donor 29 | rectum |
17 | chr14:105373400-105373600 | Bivalent Enhancer | H1 Derived Mesenchymal Stem Cells | ES cell derived |